骨髓增殖性疾病中的表型与基因型 - Suppr

Phenotype and genotype in the myeloproliferative disorders.

作者信息

Spivak Jerry L

机构信息

Hematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2109, USA.

出版信息

Eur J Haematol Suppl. 2007 Oct(68):9-12. doi: 10.1111/j.1600-0609.2007.00936.x.

DOI:10.1111/j.1600-0609.2007.00936.x

PMID:17727558

Abstract

摘要

相似文献

Phenotype and genotype in the myeloproliferative disorders.

Eur J Haematol Suppl. 2007 Oct(68):9-12. doi: 10.1111/j.1600-0609.2007.00936.x.

Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations.

Haematologica. 2008 Jul;93(7):972-6. doi: 10.3324/haematol.13266.

Myelodysplastic/myeloproliferative disorders.

Haematologica. 2008 Jan;93(1):4-6. doi: 10.3324/haematol.11374.

[Clinical aspects of myeloproliferative disorders excluding CML].

Rinsho Ketsueki. 2008 Oct;49(10):1411-9.

Different lineage involvement in myelodysplastic/myeloproliferative disease with combined MPLW515L and JAK2V617F mutation.

Br J Haematol. 2009 Jun;145(5):673-5. doi: 10.1111/j.1365-2141.2009.07671.x. Epub 2009 Mar 31.

Advances in the understanding and management of myeloproliferative disorders.

Eur J Haematol Suppl. 2007 Oct(68):2-4. doi: 10.1111/j.1600-0609.2007.00934.x.

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.

Leukemia. 2010 Apr;24(4):859-60. doi: 10.1038/leu.2010.1. Epub 2010 Jan 28.

Primary myelofibrosis and its paraneoplastic stromal effects.

Haematologica. 2007 May;92(5):577-9. doi: 10.3324/haematol.11457.

An update of molecular pathogenesis and diagnosis of myeloproliferative disorders in the JAK2 era.

Chin Med J (Engl). 2008 Sep 20;121(18):1838-42.

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.

Eur J Haematol Suppl. 2007 Oct(68):5-8. doi: 10.1111/j.1600-0609.2007.00935.x.

引用本文的文献

Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study.

World J Gastroenterol. 2011 Nov 14;17(42):4704-10. doi: 10.3748/wjg.v17.i42.4704.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Phenotype and genotype in the myeloproliferative disorders.

Eur J Haematol Suppl. 2007 Oct(68):9-12. doi: 10.1111/j.1600-0609.2007.00936.x.

Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations.

Haematologica. 2008 Jul;93(7):972-6. doi: 10.3324/haematol.13266.

Myelodysplastic/myeloproliferative disorders.

Haematologica. 2008 Jan;93(1):4-6. doi: 10.3324/haematol.11374.

[Clinical aspects of myeloproliferative disorders excluding CML].

Rinsho Ketsueki. 2008 Oct;49(10):1411-9.

Different lineage involvement in myelodysplastic/myeloproliferative disease with combined MPLW515L and JAK2V617F mutation.

Br J Haematol. 2009 Jun;145(5):673-5. doi: 10.1111/j.1365-2141.2009.07671.x. Epub 2009 Mar 31.

Advances in the understanding and management of myeloproliferative disorders.

Eur J Haematol Suppl. 2007 Oct(68):2-4. doi: 10.1111/j.1600-0609.2007.00934.x.

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.

Leukemia. 2010 Apr;24(4):859-60. doi: 10.1038/leu.2010.1. Epub 2010 Jan 28.

Primary myelofibrosis and its paraneoplastic stromal effects.

Haematologica. 2007 May;92(5):577-9. doi: 10.3324/haematol.11457.

An update of molecular pathogenesis and diagnosis of myeloproliferative disorders in the JAK2 era.

Chin Med J (Engl). 2008 Sep 20;121(18):1838-42.

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.

Eur J Haematol Suppl. 2007 Oct(68):5-8. doi: 10.1111/j.1600-0609.2007.00935.x.

引用本文的文献

Epidemiological aspects of Budd-Chiari in Egyptian patients: a single-center study.

World J Gastroenterol. 2011 Nov 14;17(42):4704-10. doi: 10.3748/wjg.v17.i42.4704.

Phenotype and genotype in the myeloproliferative disorders.

作者信息

Spivak Jerry L

机构信息

Hematology Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2109, USA.

出版信息

Eur J Haematol Suppl. 2007 Oct(68):9-12. doi: 10.1111/j.1600-0609.2007.00936.x.

DOI:10.1111/j.1600-0609.2007.00936.x

PMID:17727558

Abstract

摘要

Phenotype and genotype in the myeloproliferative disorders.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Phenotype and genotype in the myeloproliferative disorders.

作者信息

机构信息

出版信息